Identification of novel sub-phenotypes of severe ARDS requiring ECMO using latent class analysis.


Journal

Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902

Informations de publication

Date de publication:
24 Oct 2024
Historique:
received: 12 05 2024
accepted: 21 10 2024
medline: 25 10 2024
pubmed: 25 10 2024
entrez: 25 10 2024
Statut: epublish

Résumé

Sub-phenotyping of acute respiratory distress syndrome (ARDS) could be useful for evaluating the severity of ARDS or predicting its responsiveness to given therapeutic strategies, but no studies have yet investigated the heterogeneity of patients with severe ARDS requiring veno-venous extracorporeal membrane oxygenation (V-V ECMO). We conducted this retrospective multicenter observational study in adult patients with severe ARDS treated by V-V ECMO. We performed latent class analysis (LCA) for identifying sub-phenotypes of severe ARDS based on the radiological and clinical findings at the start of ECMO support. Multivariate Cox regression analysis was conducted to investigate the differences in mortality and association between the PEEP setting of ≥ 10 cmH We identified three sub-phenotypes from analysis of the data of a total of 544 patients with severe ARDS treated by V-V ECMO, as follows: Dry type (n = 185; 34%); Wet type (n = 169; 31%); and Fibrotic type (n = 190; 35%). The 90-days in-hospital mortality risk was higher in the patients with the Fibrotic type than in those with the Dry type (adjusted hazard ratio [95% confidence interval] 1.75 [1.10-2.79], p = 0.019) or the Wet type (1.50 [1.02-2.23], p = 0.042). The PEEP setting of ≥ 10 cmH The three sub-phenotypes showed different mortality rates and different relationships between higher PEEP settings in the early phase of V-V ECMO and patient outcomes. Our data suggest that we may need to change our management approach to patients with severe ARDS during V-V ECMO according to their clinical sub-phenotype.

Sections du résumé

BACKGROUND BACKGROUND
Sub-phenotyping of acute respiratory distress syndrome (ARDS) could be useful for evaluating the severity of ARDS or predicting its responsiveness to given therapeutic strategies, but no studies have yet investigated the heterogeneity of patients with severe ARDS requiring veno-venous extracorporeal membrane oxygenation (V-V ECMO).
METHODS METHODS
We conducted this retrospective multicenter observational study in adult patients with severe ARDS treated by V-V ECMO. We performed latent class analysis (LCA) for identifying sub-phenotypes of severe ARDS based on the radiological and clinical findings at the start of ECMO support. Multivariate Cox regression analysis was conducted to investigate the differences in mortality and association between the PEEP setting of ≥ 10 cmH
RESULTS RESULTS
We identified three sub-phenotypes from analysis of the data of a total of 544 patients with severe ARDS treated by V-V ECMO, as follows: Dry type (n = 185; 34%); Wet type (n = 169; 31%); and Fibrotic type (n = 190; 35%). The 90-days in-hospital mortality risk was higher in the patients with the Fibrotic type than in those with the Dry type (adjusted hazard ratio [95% confidence interval] 1.75 [1.10-2.79], p = 0.019) or the Wet type (1.50 [1.02-2.23], p = 0.042). The PEEP setting of ≥ 10 cmH
CONCLUSIONS CONCLUSIONS
The three sub-phenotypes showed different mortality rates and different relationships between higher PEEP settings in the early phase of V-V ECMO and patient outcomes. Our data suggest that we may need to change our management approach to patients with severe ARDS during V-V ECMO according to their clinical sub-phenotype.

Identifiants

pubmed: 39449081
doi: 10.1186/s13054-024-05143-3
pii: 10.1186/s13054-024-05143-3
doi:

Types de publication

Journal Article Observational Study Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

343

Subventions

Organisme : JSPS KAKENHI
ID : JP 22K09120
Organisme : Japanese Association for Acute Medicine, and Japan Agency for Medical Research and Development
ID : JP23fk0108654

Investigateurs

Jun Hamaguchi (J)
Kazuki Matsumura (K)
Kenji Fujizuka (K)
Yoshihiro Hagiwara (Y)
Ryuichi Nakayama (R)
Naofumi Bunya (N)
Junichi Maruyama (J)
Takayuki Ogura (T)
Mitsunobu Nakamura (M)
Keiki Shimizu (K)
Mamoru Masuda (M)

Informations de copyright

© 2024. The Author(s).

Références

Friedrichson B, Mutlak H, Zacharowski K, Piekarski F. Insight into ECMO, mortality and ARDS: a nationwide analysis of 45,647 ECMO runs. Crit Care. 2021;25:38.
doi: 10.1186/s13054-021-03463-2 pubmed: 33509228 pmcid: 7841040
Barbaro RP, Odetola FO, Kidwell KM, Paden ML, Bartlett RH, Davis MM, Annich GM. Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry. Am J Respir Crit Care Med. 2015;191:894–901.
doi: 10.1164/rccm.201409-1634OC pubmed: 25695688 pmcid: 4435456
Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA, Network NA. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014;2:611–20.
doi: 10.1016/S2213-2600(14)70097-9 pubmed: 24853585 pmcid: 4154544
Wilson JG, Calfee CS. ARDS Subphenotypes: understanding a heterogeneous syndrome. Crit Care. 2020;24:102.
doi: 10.1186/s13054-020-2778-x pubmed: 32204722 pmcid: 7092435
Sinha P, Furfaro D, Cummings MJ, Abrams D, Delucchi K, Maddali MV, He J, Thompson A, Murn M, Fountain J, Rosen A, Robbins-Juarez SY, Adan MA, Satish T, Madhavan M, Gupta A, Lyashchenko AK, Agerstrand C, Yip NH, Burkart KM, Beitler JR, Baldwin MR, Calfee CS, Brodie D, O’Donnell MR. Latent class analysis reveals COVID-19-related acute respiratory distress syndrome subgroups with differential responses to corticosteroids. Am J Respir Crit Care Med. 2021;204:1274–85.
doi: 10.1164/rccm.202105-1302OC pubmed: 34543591 pmcid: 8786071
Famous KR, Delucchi K, Ware LB, Kangelaris KN, Liu KD, Thompson BT, Calfee CS, Network A. Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med. 2017;195:331–8.
doi: 10.1164/rccm.201603-0645OC pubmed: 27513822 pmcid: 5328179
The Extracorporeal Life Support Organization, Extracorporeal Life Support Guidelines, Patient Care Practice Guidelines. In: Editor (ed)^(eds) Book The Extracorporeal Life Support Organization, Extracorporeal Life Support Guidelines, Patient Care Practice Guidelines. City, pp.
Qadir N, Sahetya S, Munshi L, Summers C, Abrams D, Beitler J, Bellani G, Brower RG, Burry L, Chen JT, Hodgson C, Hough CL, Lamontagne F, Law A, Papazian L, Pham T, Rubin E, Siuba M, Telias I, Patolia S, Chaudhuri D, Walkey A, Rochwerg B, Fan E. An update on management of adult patients with acute respiratory distress syndrome: an official american thoracic society clinical practice guideline. Am J Respir Crit Care Med. 2024;209:24–36.
doi: 10.1164/rccm.202311-2011ST pubmed: 38032683 pmcid: 10870893
Tonna JE, Abrams D, Brodie D, Greenwood JC, Rubio Mateo-Sidron JA, Usman A, Fan E. Management of adult patients supported with venovenous extracorporeal membrane oxygenation (VV ECMO): guideline from the extracorporeal life support organization (ELSO). ASAIO J. 2021;67:601–10.
doi: 10.1097/MAT.0000000000001432 pubmed: 33965970 pmcid: 8315725
Richard C, Argaud L, Blet A, Boulain T, Contentin L, Dechartres A, Dejode JM, Donetti L, Fartoukh M, Fletcher D, Kuteifan K, Lasocki S, Liet JM, Lukaszewicz AC, Mal H, Maury E, Osman D, Outin H, Richard JC, Schneider F, Tamion F. Extracorporeal life support for patients with acute respiratory distress syndrome: report of a Consensus Conference. Ann Intensive Care. 2014;4:15.
doi: 10.1186/2110-5820-4-15 pubmed: 24936342 pmcid: 4046033
Nishikimi M, Ohshimo S, Fukumoto W, Hamaguchi J, Matsumura K, Fujizuka K, Hagiwara Y, Nakayama R, Bunya N, Maruyama J, Abe T, Anzai T, Ogata Y, Naito H, Amemiya Y, Ikeda T, Yagi M, Furukawa Y, Taniguchi H, Yagi T, Katsuta K, Konno D, Suzuki G, Kawasaki Y, Hattori N, Nakamura T, Kondo N, Kikuchi H, Kai S, Ichiyama S, Awai K, Takahashi K, Shime N, group JCr. Chest CT findings in severe acute respiratory distress syndrome requiring V-V ECMO: J-CARVE registry. J Intensive Care. 2024;12:5.
doi: 10.1186/s40560-023-00715-x pubmed: 38273416 pmcid: 10811928
Sheard S, Rao P, Devaraj A. Imaging of acute respiratory distress syndrome. Respir Care. 2012;57:607–12.
doi: 10.4187/respcare.01731 pubmed: 22472500
Zompatori M, Ciccarese F, Fasano L. Overview of current lung imaging in acute respiratory distress syndrome. Eur Respir Rev. 2014;23:519–30.
doi: 10.1183/09059180.00001314 pubmed: 25445951 pmcid: 9487404
Force ADT, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526–33.
Pelosi P, D’Onofrio D, Chiumello D, Paolo S, Chiara G, Capelozzi VL, Barbas CS, Chiaranda M, Gattinoni L. Pulmonary and extrapulmonary acute respiratory distress syndrome are different. Eur Respir J Suppl. 2003;42:48s–56s.
doi: 10.1183/09031936.03.00420803 pubmed: 12946001
Luo L, Shaver CM, Zhao Z, Koyama T, Calfee CS, Bastarache JA, Ware LB. Clinical predictors of hospital mortality differ between direct and indirect ARDS. Chest. 2017;151:755–63.
doi: 10.1016/j.chest.2016.09.004 pubmed: 27663180
Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5:1315–6.
doi: 10.1097/JTO.0b013e3181ec173d pubmed: 20736804
OECD database. In: Editor (ed)^(eds) Book OECD database. City, pp.
Filippini DFL, Di Gennaro E, van Amstel RBE, Beenen LFM, Grasso S, Pisani L, Bos LDJ, Smit MR. Latent class analysis of imaging and clinical respiratory parameters from patients with COVID-19-related ARDS identifies recruitment subphenotypes. Crit Care. 2022;26:363.
doi: 10.1186/s13054-022-04251-2 pubmed: 36434629 pmcid: 9700924
Redaelli S, von Wedel D, Fosset M, Suleiman A, Chen G, Alingrin J, Gong MN, Gajic O, Goodspeed V, Talmor D, Schaefer MS, Jung B. Inflammatory subphenotypes in patients at risk of ARDS: evidence from the LIPS-A trial. Intensive Care Med. 2023;49:1499–507.
doi: 10.1007/s00134-023-07244-z pubmed: 37906258
Sinha P, Delucchi KL, Thompson BT, McAuley DF, Matthay MA, Calfee CS, Network NA. Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study. Intensive Care Med. 2018;44:1859–69.
doi: 10.1007/s00134-018-5378-3 pubmed: 30291376 pmcid: 6317524
Kitsios GD, Yang L, Manatakis DV, Nouraie M, Evankovich J, Bain W, Dunlap DG, Shah F, Barbash IJ, Rapport SF, Zhang Y, DeSensi RS, Weathington NM, Chen BB, Ray P, Mallampalli RK, Benos PV, Lee JS, Morris A, McVerry BJ. Host-response subphenotypes offer prognostic enrichment in patients with or at risk for acute respiratory distress syndrome. Crit Care Med. 2019;47:1724–34.
doi: 10.1097/CCM.0000000000004018 pubmed: 31634231 pmcid: 6865808
Calfee CS, Delucchi KL, Sinha P, Matthay MA, Hackett J, Shankar-Hari M, McDowell C, Laffey JG, O’Kane CM, McAuley DF, Trials ICC. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. Lancet Respir Med. 2018;6:691–8.
doi: 10.1016/S2213-2600(18)30177-2 pubmed: 30078618 pmcid: 6201750
Maddali MV, Churpek M, Pham T, Rezoagli E, Zhuo H, Zhao W, He J, Delucchi KL, Wang C, Wickersham N, McNeil JB, Jauregui A, Ke S, Vessel K, Gomez A, Hendrickson CM, Kangelaris KN, Sarma A, Leligdowicz A, Liu KD, Matthay MA, Ware LB, Laffey JG, Bellani G, Calfee CS, Sinha P, Investigators the ETG. Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis. Lancet Respir Med. 2022;10:367–77.
doi: 10.1016/S2213-2600(21)00461-6 pubmed: 35026177 pmcid: 8976729
Cabrera-Benitez NE, Laffey JG, Parotto M, Spieth PM, Villar J, Zhang H, Slutsky AS. Mechanical ventilation-associated lung fibrosis in acute respiratory distress syndrome: a significant contributor to poor outcome. Anesthesiology. 2014;121:189–98.
doi: 10.1097/ALN.0000000000000264 pubmed: 24732023
Marshall RP, Bellingan G, Webb S, Puddicombe A, Goldsack N, McAnulty RJ, Laurent GJ. Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am J Respir Crit Care Med. 2000;162:1783–8.
doi: 10.1164/ajrccm.162.5.2001061 pubmed: 11069813
Nieman GF, Gatto LA, Habashi NM. Impact of mechanical ventilation on the pathophysiology of progressive acute lung injury. J Appl Physiol. 2015;119:1245–61.
doi: 10.1152/japplphysiol.00659.2015 pubmed: 26472873
Malbouisson LM, Muller JC, Constantin JM, Lu Q, Puybasset L, Rouby JJ, Group CTSAS. Computed tomography assessment of positive end-expiratory pressure-induced alveolar recruitment in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;163:1444–50.
doi: 10.1164/ajrccm.163.6.2005001 pubmed: 11371416
Schmidt M, Pham T, Arcadipane A, Agerstrand C, Ohshimo S, Pellegrino V, Vuylsteke A, Guervilly C, McGuinness S, Pierard S, Breeding J, Stewart C, Ching SSW, Camuso JM, Stephens RS, King B, Herr D, Schultz MJ, Neuville M, Zogheib E, Mira JP, Roze H, Pierrot M, Tobin A, Hodgson C, Chevret S, Brodie D, Combes A. Mechanical ventilation management during extracorporeal membrane oxygenation for acute respiratory distress syndrome. an international multicenter prospective cohort. Am J Respir Crit Care Med. 2019;200:1002–12.
doi: 10.1164/rccm.201806-1094OC pubmed: 31144997
Schmidt M, Stewart C, Bailey M, Nieszkowska A, Kelly J, Murphy L, Pilcher D, Cooper DJ, Scheinkestel C, Pellegrino V, Forrest P, Combes A, Hodgson C. Mechanical ventilation management during extracorporeal membrane oxygenation for acute respiratory distress syndrome: a retrospective international multicenter study. Crit Care Med. 2015;43:654–64.
doi: 10.1097/CCM.0000000000000753 pubmed: 25565460
Hemmila MR, Rowe SA, Boules TN, Miskulin J, McGillicuddy JW, Schuerer DJ, Haft JW, Swaniker F, Arbabi S, Hirschl RB, Bartlett RH. Extracorporeal life support for severe acute respiratory distress syndrome in adults. Ann Surg. 2004;240:595–605.
doi: 10.1097/01.sla.0000141159.90676.2d pubmed: 15383787 pmcid: 1356461

Auteurs

Mitsuaki Nishikimi (M)

Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. m0528332626@yahoo.co.jp.

Shinichiro Ohshimo (S)

Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Giacomo Bellani (G)

Centre for Medical Sciences-CISMed, University of Trento, Trento, Italy.
Department of Anesthesia and Intensive Care, Santa Chiara Hospital, APSS Trento Largo Medaglie d'Oro Trento, Trento, Italy.

Wataru Fukumoto (W)

Department of Diagnostic Radiology, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.

Tatsuhiko Anzai (T)

M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan.

Keibun Liu (K)

Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia.
Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia.
Non-Profit Organization ICU Collaboration Network (ICON), Tokyo, Japan.

Junki Ishii (J)

Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Michihito Kyo (M)

Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Kazuo Awai (K)

Department of Diagnostic Radiology, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.

Kunihiko Takahashi (K)

M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan.

Nobuaki Shime (N)

Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH